Asset Dedication’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Asset Dedication's RPRX Position: Q3 2026 in Review
Asset Dedication sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 49 shares — an estimated $2.75K sold.
Asset Dedication first reported a position in RPRX in Q2 2026 and held it in 1 quarter. The position peaked at $2.75K in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Asset Dedication reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
- Asset Dedication sold 49 Royalty Pharma shares in Q3 2026, an estimated $2.75K.
- Asset Dedication first reported a position in Royalty Pharma in Q2 2026 and held it in 1 quarter.
- Asset Dedication's Royalty Pharma position peaked at $2.75K in Q2 2026.
- 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.